A Suggested Approach to Simplify and Improve Cervical Screening in the United States
Authors:
- 1 January 2016
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 20 (1) , 1-7
Abstract
Cervical cancer prevention strategies in the United States have become complicated and even controversial, despite advanced understanding of carcinogenic human papillomavirus (HPV) infection as the necessary causal agent. Twenty years ago, etiologic and methodologic studies had already yielded 2 powerful preventive approaches. There are excellent vaccines to prevent the most carcinogenic types of HPV infection; reduced HPV endemicity will ultimately prevent a large fraction of cervical precancer and cancers. For prevention of cervical cancer in the interim, sensitive HPV tests that target women at risk of cancer, by detection of the DNA/RNA of approximately a dozen carcinogenic HPV types, permit early diagnosis and treatment of precancers. Although HPV vaccines and tests have continued to improve, implementation of these new HPV-based prevention methods has been relatively slow in the United States and in most places worldwide. Increasing vaccination rates is the clearest and most vital long-term priority. But, for decades to come, screening will also be important. To promote useful discussion, this commentary will raise some current critical issues in simplifying and speeding the rational introduction of HPV molecular methods into US cervical screening.Keywords
This publication has 60 references indexed in Scilit:
- A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic resultsGynecologic Oncology, 2015
- The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developmentsInternational Journal of Cancer, 2014
- Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-PositiveJournal of Lower Genital Tract Disease, 2013
- CADM1andMALpromoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical diseaseInternational Journal of Cancer, 2013
- Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV studyAmerican Journal of Obstetrics and Gynecology, 2013
- Comparing the performance of six human papillomavirus tests in a screening populationBritish Journal of Cancer, 2013
- Evaluation of 14 triage strategies for HPV DNA‐positive women in population‐based cervical screeningInternational Journal of Cancer, 2011
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- Cervical cancer screening following prophylactic human papillomavirus vaccinationVaccine, 2008
- A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV TypesThe Journal of Infectious Diseases, 2001